Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Sirot

Showing results (11-20 of 96) with videos related to

Pageof 10
Sort By:
Pathologie-Biologie|June 1, 1985
[In vitro effect of ceftriaxone on hospital bacteria. Line of regression and critical values]M Cluzel, M Chanal, D Sirot, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1990
Molecular epidemiology of TEM-3 (CTX-1) beta-lactamaseA Petit, G Gerbaud, D Sirot, et al.
The Journal of Antimicrobial Chemotherapy|September 1, 1989
Interactions of meropenem, with beta-lactamases, including enzymes with extended-spectrum activity against third-generation cephalosporinsR Labia, A Morand, K Tiwari, et al.
Pathologie-Biologie|June 1, 1983
[Effect of trimethoprim at a subinhibitory concentration on the appearance of mutants resistant to rifampicin]B Joly, D Sirot, J Sirot, et al.
Pathologie-Biologie|June 1, 1984
[Comparative activity of sulfamethoxazole-trimethoprim (SMZ-TMP) on bacteria responsible for ORL infections]B Joly, D Sirot, M Cluzel, et al.
Pathologie-Biologie|June 1, 1982
[Statistical regression analysis for four new cephalosporins (author's transl)]D Sirot, Y Glanddier, M Chanal, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1995
Molecular characterization of nine different types of mutants among 107 inhibitor-resistant TEM beta-lactamases from clinical isolates of Escherichia coliC Henquell, C Chanal, D Sirot, et al.
Pathologie-Biologie|October 1, 1985
[Carbenicillin resistance of gram-negative bacteria: incidence, biochemical and genetic determinism]S Shaokat, B Joly, A Philippon, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1987
Spread of SHV-1 beta-lactamase in Escherichia coli isolated from fecal samples in AfricaS Shaokat, M Ouellette, D Sirot, et al.
The Journal of Antimicrobial Chemotherapy|August 1, 1996
Characterization of an inhibitor-resistant enzyme IRT-2 derived from TEM-2 beta-lactamase produced by Proteus mirabilis strainsL Bret, C Chanal, D Sirot, et al.
Pageof 10

Showing results (11-20 of 96) with videos related to

Sort By:
Pageof 10
Pathologie-Biologie|June 1, 1985
[In vitro effect of ceftriaxone on hospital bacteria. Line of regression and critical values]M Cluzel, M Chanal, D Sirot, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1990
Molecular epidemiology of TEM-3 (CTX-1) beta-lactamaseA Petit, G Gerbaud, D Sirot, et al.
The Journal of Antimicrobial Chemotherapy|September 1, 1989
Interactions of meropenem, with beta-lactamases, including enzymes with extended-spectrum activity against third-generation cephalosporinsR Labia, A Morand, K Tiwari, et al.
Pathologie-Biologie|June 1, 1983
[Effect of trimethoprim at a subinhibitory concentration on the appearance of mutants resistant to rifampicin]B Joly, D Sirot, J Sirot, et al.
Pathologie-Biologie|June 1, 1984
[Comparative activity of sulfamethoxazole-trimethoprim (SMZ-TMP) on bacteria responsible for ORL infections]B Joly, D Sirot, M Cluzel, et al.
Pathologie-Biologie|June 1, 1982
[Statistical regression analysis for four new cephalosporins (author's transl)]D Sirot, Y Glanddier, M Chanal, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1995
Molecular characterization of nine different types of mutants among 107 inhibitor-resistant TEM beta-lactamases from clinical isolates of Escherichia coliC Henquell, C Chanal, D Sirot, et al.
Pathologie-Biologie|October 1, 1985
[Carbenicillin resistance of gram-negative bacteria: incidence, biochemical and genetic determinism]S Shaokat, B Joly, A Philippon, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1987
Spread of SHV-1 beta-lactamase in Escherichia coli isolated from fecal samples in AfricaS Shaokat, M Ouellette, D Sirot, et al.
The Journal of Antimicrobial Chemotherapy|August 1, 1996
Characterization of an inhibitor-resistant enzyme IRT-2 derived from TEM-2 beta-lactamase produced by Proteus mirabilis strainsL Bret, C Chanal, D Sirot, et al.
Pageof 10